127 related articles for article (PubMed ID: 3252557)
1. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
Sakuma H; Takase S; Mizuno Y; Teramura K; Hanew K
Tohoku J Exp Med; 1988 Nov; 156(3):291-8. PubMed ID: 3252557
[TBL] [Abstract][Full Text] [Related]
2. Tuberoinfundibular dopaminergic system and anterior pituitary dopamine receptor in Shy-Drager syndrome.
Konagaya Y; Konagaya M; Takayanagi T
J Neurol Sci; 1985 Jan; 67(1):93-103. PubMed ID: 3981215
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
4. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
5. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
Fine SA; Frohman LA
J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
7. Prolactin and growth hormone response to levodopa in affective illness.
Linkowski P; Brauman H; Mendlewicz J
Neuropsychobiology; 1983; 9(2-3):108-12. PubMed ID: 6621850
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients.
Cusimano G; Capriani C; Bonifati V; Meco G
Acta Neurol Scand; 1991 Mar; 83(3):145-50. PubMed ID: 1903236
[TBL] [Abstract][Full Text] [Related]
9. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
Casanueva FF; Villanueva L; Peñalva A; Cabezas-Cerrato J
Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
[TBL] [Abstract][Full Text] [Related]
10. L-dopa absorption and the pituitary-hypothalamic axis.
Boyd AE; Angoff G; Long A; Mager M
J Clin Endocrinol Metab; 1978 Dec; 47(6):1341-7. PubMed ID: 263355
[TBL] [Abstract][Full Text] [Related]
11. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
Delitala G
Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
[TBL] [Abstract][Full Text] [Related]
12. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
13. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man.
Vance ML; Kaiser DL; Frohman LA; Rivier J; Vale WW; Thorner MO
J Clin Endocrinol Metab; 1987 Jun; 64(6):1136-41. PubMed ID: 3553220
[TBL] [Abstract][Full Text] [Related]
14. Effect of some peptides on dopaminergic function in man.
Lal S; Nair NP; Isaac I; Thavundayil J; Guyda H
J Neural Transm Suppl; 1990; 29():173-81. PubMed ID: 2113567
[TBL] [Abstract][Full Text] [Related]
15. Effect of sulpiride on serum growth hormone and prolactin concentrations following L-DOPA administration in man.
Mori M; Kobayashi I; Shimoyama S; Uehara T; Nemoto T
Endocrinol Jpn; 1977 Apr; 24(2):149-53. PubMed ID: 406134
[TBL] [Abstract][Full Text] [Related]
16. Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine.
Kamal TJ; Molitch ME
Am J Med Sci; 1992 Nov; 304(5):289-93. PubMed ID: 1332473
[TBL] [Abstract][Full Text] [Related]
17. Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response.
Agnoli A; Baldassarre M; Ruggieri S; Falaschi P; Urso RD; Rocco A
J Neural Transm; 1981; 51(1-2):123-34. PubMed ID: 7264625
[TBL] [Abstract][Full Text] [Related]
18. Dynamic evaluation of growth hormone (GH) and prolactin (hPRL) secretion in active acromegaly with high and low GH output.
Tolis G; Kovacs L; Friesen H; Martin JB
Acta Endocrinol (Copenh); 1975 Feb; 78(2):251-7. PubMed ID: 803748
[TBL] [Abstract][Full Text] [Related]
19. No acute effect of pimozide on the plasma GH levels in acromegaly.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1983 Aug; 103(4):461-8. PubMed ID: 6613492
[TBL] [Abstract][Full Text] [Related]
20. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
Wu X; Gu Q; Su Y
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
